Overview
Modern lung cancer care is biomarker-driven: EGFR, ALK and other mutations open targeted-pill options; PD-L1 levels guide immunotherapy; stage decides surgery versus radiation versus systemic therapy. Getting staging and molecular testing right β before treatment starts β is the highest-stakes step.
In Beijing
Beijing Cancer Hospital runs comprehensive thoracic oncology: low-dose CT and PET-CT staging within days, EBUS and biopsy, thoracic surgery, radiotherapy and one of China's largest lung-cancer trial programs. Chinese-approved targeted drugs and PD-1 agents frequently cost 60β80% less than Western list prices.
Typical costs
- Chest CT: from about $250 Β· PET-CT staging: from about $600
- Pathology + molecular re-review with written plan: from $400
- Treatment courses: individual quote
How we help
Send your records for a free assessment β we return a written plan and itemized quote, arrange the right specialist and interpreter, and coordinate everything on the ground.